Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.160
+0.140 (3.48%)
Dec 23, 2025, 4:00 PM EST - Market closed
Evolent Health Market Cap
Evolent Health has a market cap or net worth of $464.26 million as of December 24, 2025. Its market cap has decreased by -64.28% in one year.
Market Cap
464.26M
Enterprise Value
1.43B
1-Year Change
-64.28%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since June 5, 2015, Evolent Health's market cap has decreased from $1.05B to $464.26M, a decrease of -55.85%. That is a compound annual growth rate of -7.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 464.30M | -64.59% |
| Dec 31, 2024 | 1.31B | -65.47% |
| Dec 29, 2023 | 3.80B | 33.63% |
| Dec 30, 2022 | 2.84B | 14.85% |
| Dec 31, 2021 | 2.47B | 79.93% |
| Dec 31, 2020 | 1.38B | 79.57% |
| Dec 31, 2019 | 765.70M | -53.32% |
| Dec 31, 2018 | 1.64B | 72.46% |
| Dec 29, 2017 | 951.20M | -5.38% |
| Dec 30, 2016 | 1.01B | 40.70% |
| Dec 31, 2015 | 714.50M | -32.05% |
| Jun 5, 2015 | 1.05B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |